Navigation Links
Hillenbrand, Inc. Reports Third-Quarter Revenue of $165 Million and Earnings Per Share of $0.42
Date:8/12/2008

ill be archived on the company's Web site through August 9, 2009, for those unable to listen to the live webcast.

Participants may listen to the conference call by dialing 1-877-419-6597 (1-719-325-4861 for international callers). A replay of the call will be

available through Aug. 21, 2008, at 1-888-203-1112 (1-719-457-0820 for international callers). Please use the confirmation code 4683815.

Hillenbrand, Inc. and Subsidiaries

Consolidated Statements of Income (Unaudited)

(Amounts in millions, except per share data)

Three Months Ended Nine Months Ended

June 30 June 30

2008 2007 2008 2007

Net revenues $165.0 $165.6 $519.3 $509.0

Cost of goods sold 98.6 98.7 302.8 293.3

Gross profit 66.4 66.9 216.5 215.7

Operating expenses (including

separation costs of $0.1 and

$14.2 in the three and nine month

periods ending June 30, 2008,

respectively.) 28.4 34.1 99.2 89.0

Operating profit 38.0 32.8 117.3 126.7

Interest expense (1.4) - (1.4) -

Investment income and other 4.4 1.0 3.9 1.0

Income before income taxes 41.0 33.8 119.8 127.7

Income tax expense 14.3 12.3 45.8 46.8

Net income $26.7 $21.5 $74.0 $80.9

Income per common share - basic

and diluted $0.42 $0.34 $1.18 $1.29

Dividends per common share* $0.1825 $- $0.1825 $-

Average common shares outstanding -


'/>"/>
SOURCE Hillenbrand, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Hillenbrand, Inc. Declares First Quarterly Dividend As a New Publicly Traded Company
2. Hillenbrand, Inc. Names Joe A. Raver President and Chief Operating Officer of Batesville Casket Company
3. Hillenbrand, Inc. Board of Directors Approves $100M Share Repurchase Program
4. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
5. Haemacure Reports Third Quarter 2007 Results
6. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
7. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
8. MDS Reports Third Quarter 2007 Results
9. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
10. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
11. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... Initiative expands to include cost...ents, teachers, and healthcare professionals in de...ton, CA (PRWEB) November 25, 2009 -- Elluminate, ... networking solutions that support 21st century t...day that its Fire and Ice initiative was awarded...
(Date:11/25/2009)...SHINGTON,Nov.25/PRNewswire-FirstCall/--TheAdvisory...lparticipateinthe21stAnnualPiperJaffrayHealthCareC...ecember2,2009at3:00PM(EST),willbetheCompany,sChief...,sChiefFinancialOfficer,MichaelT.Kirshbaum.Thepres...ite,foundat http://www.advisoryboardcompany.com ,t...
(Date:11/25/2009)....CLEMENS,Mich.,Nov.25/PRNewswire/--TwomoreH1N1vacc...urday,Dec.5,theMacombCountyHealthDepartmentannounc...aceatFreedomHillCountyParkinSterlingHeights. ,,...newillrunfrom9a.m.to3p.m.Thethimerosol-freeversion...hilesupplieslast.Bothinjectableandnasalsprayimmuni...
(Date:11/25/2009)...iftistheLargestDonationEverMadeinSupportofFeedingA...PRNewswire-USNewswire/--FeedingAmerica,thenation,s...milliondonationfromtheBankofAmericaCharitableFound...incomeAmericanswiththeSupplementalNutritionAssista...ThefundswillbeusedtohelpFeedingAmericafoodbanksimp...
(Date:11/25/2009)...CaliforniaMakesLittleProgresstoImproveOverallOutco...ire-USNewswire/-- Today,LungCancerAlliance-Califo...cer .The2009ReportCardisanassessmentofprogressbein...a.LCA-CAisachapterofLungCancerAlliance(LCA),theonl...supportandadvocacyforpeoplelivingwithoratriskforlu...
Breaking Medicine News(10 mins):Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 3Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 4Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 5Health News:Macomb County Health Department Schedules Two More H1N1 Flu Vaccine Clinics Dec. 3 and 5 2Health News:Bank of America Charitable Foundation Presents $1 Million Contribution to Feeding America in an Effort to Help Connect Low-Income Americans With Federal Nutrition Programs 2Health News:Bank of America Charitable Foundation Presents $1 Million Contribution to Feeding America in an Effort to Help Connect Low-Income Americans With Federal Nutrition Programs 3Health News:Lung Cancer Alliance-California Releases 2nd Annual State-Specific Report Card On Lung Cancer 2
... Washington, DC-New survey undertaken among eighty...s the highest levels of intolerance of foreigners ...seems to be at an all time high. It is clear that...embittered and torn Iraqi nation. The analysis is ...
... Washington, D.C. – The hookah, a contraption used...ming so rampant, enough to call it an epidemic of ...s said that smokers who use the hookah , are under...ces don't realize that they could be inhaling what...
... About one in every 523 children and adolescents i...es in 2001, according to estimates // from a major...h. SEARCH is the largest surveillance effort ...and prevention at Wake Forest University School of...
... One in three doctors agree that free drug samples...tative US survey published in the Journal of Medic... doctors are more likely to be influenced by incen...ists about their relationships with the pharmaceut...
... Contrast-enhanced sonography shows liver and sple...graphy, according to a study conducted // at the U...department of radiology in Sacramento, CA. T...onography revealed 11 (50%). “The main focus ...
... A special blood concentrate known as platelet-ric... of medical and surgical situations, // but resear...ccepted approach to measuring the platelet concent...telet counts in PRP preparations, using standard h...
Other Medicine News:Health News:Iraqi’s Gripped with Insecurit 2Health News:Iraqi’s Gripped with Insecurit 3Health News:Hooked on the Hookah, a’int no good 2Health News:Hooked on the Hookah, a’int no good 3Health News:One in 523 Children and Adolescents Have Diabetes 2Health News:One in 523 Children and Adolescents Have Diabetes 3Health News:Free Drug Samples Influence Prescribing, Say One in Three Doctors 2Health News:Automated Technique Accurately Measures Platelet Counts in "Platelet Gel" Products 2
(Date:11/25/2009)...RK,Nov.25/PRNewswire/--Reportlinker.comannouncesth...e: ,, IntranasalDrugDelivery-USMarketTrends&am...ntranasal-Drug-Delivery---US-Market-Trends--Analys...witnessinganexpansionoftherapeuticapplicationsfrom...edeliveryofsystemictherapeuticdrugs.Thefutureofthe...
(Date:11/25/2009)...AINVIEW,Calif.,Nov.25/PRNewswire/-- ChemoCentryx,...theCompany,sPROTECT-1(theProspectiveRandomizedOral...EN(TM)(CCX282-B)inpatientswithmoderate-to-severeCr...ablesafetyandtolerabilityprofile.Thestudydemonstra...seseverityasdefinedasa70-pointdecreaseintheCrohn,s...
(Date:11/24/2009)...E,Calif.,Nov.24/PRNewswire-FirstCall/--Endologix,I...atmentsforaorticdisorders,announcedtodaythatithasf...epatentinfringementlawsuitbroughtagainstitinOctobe...DistrictCourtinIndianapolis,Indiana. ,, Endolog...tedStatesPatentandTrademarkOffice(USPTO)conductspr...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Reportlinker Adds Novo Nordisk A S 3A PharmaVitae Profile 58967 1Reportlinker Adds Novo Nordisk A S 3A PharmaVitae Profile 58967 2Reportlinker Adds Novo Nordisk A S 3A PharmaVitae Profile 58967 3Reportlinker Adds Novo Nordisk A S 3A PharmaVitae Profile 58967 4Reportlinker Adds Novo Nordisk A S 3A PharmaVitae Profile 58967 5Autism Stats Exaggerated 3A Parents Pushing Back This Weekend 58962 1Autism Stats Exaggerated 3A Parents Pushing Back This Weekend 58962 2Integrated Benefits Institute Announces Availability of 2008 IBI Benchmarking Industry Reports 58957 1Integrated Benefits Institute Announces Availability of 2008 IBI Benchmarking Industry Reports 58957 2Integrated Benefits Institute Announces Availability of 2008 IBI Benchmarking Industry Reports 58957 3
...utics,Inc. (CTI) (Nasdaq: CTIC ; MTA) today annou... accepted for review CTI,s Marketing Authorization...glumex, CT-2103) for,first-line treatment of patie...COG (Eastern Cooperative Oncology Group) performan...ginning of March. The validation of the MAA,for XY...
...ics, Inc.,(Nasdaq: CVTX ) today announced new dat... of the American College of Cardiology shows that,...gnificantly reduced the,risk of recurrent ischemia...fication of antianginal therapy (p=0.009) in angin..., Additionally, Ranexa significantly improved all...
Other Medicine Technology:European Regulatory Agency Accepts Cell Therapeutics, Inc.'s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review 2European Regulatory Agency Accepts Cell Therapeutics, Inc.'s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review 3European Regulatory Agency Accepts Cell Therapeutics, Inc.'s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review 4CV Therapeutics' Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina 2CV Therapeutics' Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina 3
Mosaic
...a Windows 2000 PC based EEG with high performance ...are. EEG-9200 provides high quality performance fr...ep lab or EEG lab. Quality EEG recording is assure...ax has high performance, high sensitivity amplifie...
Neuropack MEB-9100 Series
X-SIZER Catheter System
Medicine Products: